Detalhe da pesquisa
1.
Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized Trial.
J Infect Dis
; 220(11): 1816-1825, 2019 10 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31418022
2.
Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50â¯years of age: A randomized trial.
Vaccine
; 36(29): 4278-4286, 2018 07 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29903674
3.
Corrigendum to 'Immunogenicity and safety of the adjuvanted recombinant zoster vaccine co-administered with the 23-valent pneumococcal polysaccharide vaccine in adults ≥50â¯years of age: A randomized trial' [Vaccine 36 (2018) 4278-4286].
Vaccine
; 37(9): 1252-1253, 2019 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-30711316